Sillanmäki, Saara
Lipponen, Jukka A.
Korkalainen, Henri
Kulkas, Antti
Leppänen, Timo
Nikkonen, Sami
Töyräs, Juha
Duce, Brett
Suni, Aaron
Kainulainen, Samu
Funding for this research was provided by:
Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (5041798, 5041803, 5041767)
Research Foundation of the Pulmonary Diseases
Finnish Anti-Tuberculosis Foundation
Competitive State Research Financing of Expert Responsibility Area of Tampere University Hospital (VTR3242, VTR3249, EVO2089)
European Union’s Horizon 2020 (965417)
Academy of Finland (323536)
NordForsk (90458)
Business Finland (5133/31/2018)
Finnish Cultural Foundation
Tampere Tuberculosis Foundation
Päivikki and Sakari Sohlberg Foundation
Maud Kuistila Memorial Foundation
Alfred Kordelin Foundation
Article History
Received: 18 February 2022
Accepted: 10 May 2022
First Online: 24 May 2022
Declarations
:
: Approval for retrospective data collection was obtained from the Institutional Human Research Ethics Committee of the Princess Alexandra Hospital (HREC/16/QPAH/021 and LNR/2019/QMS/54313). The need for informed consent was waived by the Metro South Human Research Ethics Committee due to the retrospective nature of the study.
: Not applicable.
: Lipponen JA is a shareholder of a company (Kubios) that designs ECG-analysis and heart rate variability analysis software. Other co-authors have nothing to declare.